AI assistant
Sending…
Instil Bio, Inc. — Director's Dealing 2021
Mar 19, 2021
33728_dirs_2021-03-18_34b29156-18cd-4de1-b4d8-d865125a8d28.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2021-03-18
Reporting Person: Binder Gwendolyn (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.35 | 2029-09-05 | Common Stock (12000) | Direct |
Footnotes
F1: Twenty-five percent (25%) of the shares subject to the option vested on June 24, 2019, and the remaining shares subject to the option vested or shall vest
in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
More from Instil Bio, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Annual Report
2026
Apr 24
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Mar 27
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2026
Jan 6
Interim / Quarterly Report
2025
Nov 13